Find My Journal

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Shukui Qin, Stephen L. Chan, Shanzhi Gu, Yuxian Bai, Zhenggang Ren, Xiaoyan Lin, Zhendong Chen, Weidong Jia, Yongdong Jin, Yabing Guo, Xiaohua Hu, Zhiqiang Meng, Jun Liang, Ying Cheng, Jianping Xiong, Hong Ren, Fang Yang, Wei Li, Yajin Chen, Yong Zeng, А. В. Султанбаев, Monika Pazgan−Simon, Margaryta Pisetska, Davide Melisi, Dmitriy Ponomarenko, Yurii Osypchuk, Ivan Sinielnikov, Tsai‐Sheng Yang, Liang Xiao, Chunxia Chen, Linna Wang, Ann-Lii Cheng, Ahmed O. Kaseb, Arndt Vogel, Shukui Qin, Stephen L Chan, Ann-Lii Cheng, Ahmed O. Kaseb, Arndt Vogel, Shanzhi Gu, Yuxian Bai, Zhenggang Ren, Xiaoyan Lin, Zhendong Chen, Weidong Jia, Yongdong Jin, Yabing Guo, Xiaohua Hu, Zhiqiang Meng, Jun Liang, Ying Cheng, Jianping Xiong, Hong Ren, Fang Yang, Wei Li, Yajin Chen, Yong Zeng, А. В. Султанбаев, Monika Pazgan−Simon, Margaryta Pisetska, Davide Melisi, Dmitriy Ponomarenko, Yurii Osypchuk, Ivan Sinielnikov, Tsai‐Sheng Yang, Liang Xiao, Chunxia Chen, Linna Wang, Mingxiang Zhang, Li Xu, Xianglin Yuan, Da Li, Jierer Ying, Jingdong Zhang, Tao Zhang, Kangsheng Gu, Yifu He, Hao Ping, Da Jiang, Shu Zhang, Baocai Xing, Baihong Zhang, Dong Wang, Xiaofeng Zhai, Houjie Liang, Bożena Cybulska-Stopa, Mikhail Dvorkin, Daniil Stroyakovskiy, M. Nechaeva, Chia‐Jui Yen, Wei‐Wen Su, Yen‐Hao Chen, Igor Bondarenko, Lin Yang, Weijia Fang, Carlos Gómez-Martín, Min‐Hee Ryu, Hansang Kim, Jeehyun Kim, Oleg Zarubenkov, Р. В. Орлова, Elena Poddubskaya, Natalia Fadeeva, Yulia Makarova, Yee Chao, Chao‐Hung Hung, Maryna Neffa, О. І. Vynnychenko, Adam M. Burgoyne, Chunyi Hao, Raphael Mohr, Robert Díaz Beveridge, Jaime Feliú-Batlle, Antonio Cubillo-Gracian, Ann‐Shing Lee, Bruno Daniele, Lorenzo Antonuzzo, Angelo Sangiovanni, Antonio Gasbarrini, Mario Scartozzi, Mi Sun Ahn, Sung‐Yong Oh, С. В. Орлов, Hakan Harputluoğlu, Berna Öksüzoğlu, Chiun Hsu, Kun‐Ming Rau, Oleksandr Krechkovskyi, Vladimir Yareshko, Henry Xiong, Fa-Chyi Lee, Yixing Jiang, Afshin Eli Gabayan, Mary K. Crow, Christophe Van Steenkiste, Gontran Verset

The Lancet, 2023

Nanjing University of Chinese Medicine, Nanjing General Hospital of Nanjing Military Command, Nanjing Medical University, Chinese University of Hong Kong, Hunan Cancer Hospital, Harbin Medical University, Fudan University, Zhongshan Hospital, Fujian Medical University, Union Hospital, Anhui Medical University, Second Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, University of Electronic Science and Technology of China, Sichuan Cancer Hospital, Nanfang Hospital, Southern Medical University, Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University, Fudan University Shanghai Cancer Center, Peking University, Peking University International Hospital, Jilin Province Tumor Hospital, Nanchang University, First Affiliated Hospital of Nanchang University, Dalian Medical University, Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, The Sixth People's Hospital of Shenyang, Jilin University, First Hospital of Jilin University, Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Sichuan University, West China Hospital of Sichuan University, Republican Oncological Clinical Dispensary, Wroclaw Medical University, University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, State Healthcare Institution "Regional Clinical Oncological Dispensary", Linkou Chang Gung Memorial Hospital, Jiangsu Hengrui Medicine (China), National Taiwan University Hospital, The University of Texas MD Anderson Cancer Center, Medizinische Hochschule Hannover

Publisher Website

Abstract

An abstract is not available for this record. Please visit the publisher website for more details.

621

Citations

View on Google Scholar